$1B-$1.15B31%
$1.45B+28%
<$850M25%
$1.3B-$1.45B23%
No price data yet
$623 Vol.Aug 7, 2026
<$850M
$80 Vol.
25%
$850M-$1B
$195 Vol.
10%
$1B-$1.15B
$111 Vol.
31%
$1.15B-$1.3B
$86 Vol.
17%
$1.3B-$1.45B
$45 Vol.
23%
$1.45B+
$65 Vol.
28%
No IPO before October 2026
$40 Vol.
6%
Rules
This market will resolve based on Latigo Biotherapeutics' market capitalization at the closing price on its first day of trading.
As of market creation, the IPO is scheduled to price on August 7 (ET). If no such IPO occurs by September 30, 2026, 11:59 PM ET, the market will resolve to "No IPO before October 2026".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.
It is calculated as the total number of outstanding shares, multiplied by the official closing share price of…